Lymphedema Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Type, By Affected Area, By End-User (Hospital, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region; Segment Forecast, 2022 - 2030
Description
Lymphedema Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Type, By Affected Area, By End-User (Hospital, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region; Segment Forecast, 2022 - 2030
The global Lymphedema treatment market size is expected t-reach USD 1,735.36 million by 2030 according t-a new study by Polaris Market Research. The report “Lymphedema Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Type, By Affected Area, By End-User (Hospital, Specialty Clinics, Ambulatory Surgical Centers, Others), By Regions; Segment Forecast, 2022 – 2030” gives a detailed insight int-current market dynamics and provides analysis on future market growth.
The increasing number of individuals being affected by Lymphedema is anticipated t-drive the growth of the Lymphedema cure industry. Additionally, with the growing prevalence of the disease, innovative and advanced treatments are being developed in order t-minimize risk during cure are als-surging. Furthermore, the increasing healthcare expenditure coupled with the growing innovation across the healthcare sector is further projected t-drive the industry growth. In addition, the launch of new medical devices by pharmaceutical companies is als-fueling industry growth across the globe.
Based on the type, the secondary Lymphedema segment is dominating the global industry and is anticipated t-lead the industry over the forecasting period. Secondary Lymphedema is generally caused by damage t-the Lymph system via cancer treatment through radiation therapy and surgery among others. According t-the CDC (Centers for Disease Control & Prevention), the majority of the patients suffer from secondary Lymphedema. Thus, the presence of a large patient pool is anticipated t-drive the growth of the segment.
The rising investment by government and private pharmaceutical companies towards R&D for drug discovery is anticipated t-present huge industry growth opportunities. Additionally, the growing prevalence of cancer and other chronic diseases is anticipated t-drive the growth of the industry. For instance, as per the International Agency for Research on Cancer (IARC), in 2018, there were nearly 17.0 million new cancer cases were recorded, which is likely t-grow t-27.5 million new cancer cases by 2040 because of the growth and aging of the population. Thereby, the rising occurrence of cancer is further acts as catalyzing factor for the market growth.
Market participants such as Avet Pharmaceuticals Inc., AIROS Medical Inc., Bio-compression Systems, Cardinal Health, Essity (BSN medical GmbH), Convatec Inc., Huntleigh Healthcare Limited, Koya Medical, JUZO, Medi GmbH, Lohmann & Rauscher, Meg-Afek ltd., PAUL HARTMANN, Smith+Nephew HERANTIS PHARMA Plc, SIGVARIS GROUP, Tactile medical, and ThermoTek are some of the key players operating in the global market.
Further, the companies are initiating collaborative initiatives in order t-increase their market share. For instance, in August 2021, AIROS Medical, announced an exclusive US distribution deal for fist assist fa-1 compression devices, enabling the company t-boost its market presence.
Polaris Market Research has segmented the lymphedema treatment market report on the basis of treatment type, affected area, end-user, and region:
Lymphedema Treatment, Treatment Type Outlook (Revenue – USD Million, 2018 – 2030)
The global Lymphedema treatment market size is expected t-reach USD 1,735.36 million by 2030 according t-a new study by Polaris Market Research. The report “Lymphedema Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Type, By Affected Area, By End-User (Hospital, Specialty Clinics, Ambulatory Surgical Centers, Others), By Regions; Segment Forecast, 2022 – 2030” gives a detailed insight int-current market dynamics and provides analysis on future market growth.
The increasing number of individuals being affected by Lymphedema is anticipated t-drive the growth of the Lymphedema cure industry. Additionally, with the growing prevalence of the disease, innovative and advanced treatments are being developed in order t-minimize risk during cure are als-surging. Furthermore, the increasing healthcare expenditure coupled with the growing innovation across the healthcare sector is further projected t-drive the industry growth. In addition, the launch of new medical devices by pharmaceutical companies is als-fueling industry growth across the globe.
Based on the type, the secondary Lymphedema segment is dominating the global industry and is anticipated t-lead the industry over the forecasting period. Secondary Lymphedema is generally caused by damage t-the Lymph system via cancer treatment through radiation therapy and surgery among others. According t-the CDC (Centers for Disease Control & Prevention), the majority of the patients suffer from secondary Lymphedema. Thus, the presence of a large patient pool is anticipated t-drive the growth of the segment.
The rising investment by government and private pharmaceutical companies towards R&D for drug discovery is anticipated t-present huge industry growth opportunities. Additionally, the growing prevalence of cancer and other chronic diseases is anticipated t-drive the growth of the industry. For instance, as per the International Agency for Research on Cancer (IARC), in 2018, there were nearly 17.0 million new cancer cases were recorded, which is likely t-grow t-27.5 million new cancer cases by 2040 because of the growth and aging of the population. Thereby, the rising occurrence of cancer is further acts as catalyzing factor for the market growth.
Market participants such as Avet Pharmaceuticals Inc., AIROS Medical Inc., Bio-compression Systems, Cardinal Health, Essity (BSN medical GmbH), Convatec Inc., Huntleigh Healthcare Limited, Koya Medical, JUZO, Medi GmbH, Lohmann & Rauscher, Meg-Afek ltd., PAUL HARTMANN, Smith+Nephew HERANTIS PHARMA Plc, SIGVARIS GROUP, Tactile medical, and ThermoTek are some of the key players operating in the global market.
Further, the companies are initiating collaborative initiatives in order t-increase their market share. For instance, in August 2021, AIROS Medical, announced an exclusive US distribution deal for fist assist fa-1 compression devices, enabling the company t-boost its market presence.
Polaris Market Research has segmented the lymphedema treatment market report on the basis of treatment type, affected area, end-user, and region:
Lymphedema Treatment, Treatment Type Outlook (Revenue – USD Million, 2018 – 2030)
- Compression Therapy
- Surgery
- Drug Therapy
- Laser Therapy
- Others
- Lower extremity
- Upper extremity
- Genitalia
- Hospital
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
- North America
- U.S.
- Canada
- Europe
- France
- Germany
- UK
- Italy
- Netherlands
- Spain
- Austria
- Asia Pacific
- China
- India
- Japan
- Malaysia
- South Korea
- Indonesia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
118 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Lymphedema Treatment Market Insights
- 4.1. Lymphedema Treatment – Industry Snapshot
- 4.2. Lymphedema Treatment Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Prevalence of lymphedema and cancer
- 4.2.1.2. Technological advancements in diagnostic imaging modalities
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Short half-life of radiopharmaceuticals
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Lymphedema Treatment Market Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Lymphedema Treatment Market, by Treatment Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 5.3. Compression Therapy
- 5.3.1. Global Lymphedema Treatment Market, by Compression Therapy, by Region, 2018 - 2030 (USD Million)
- 5.4. Surgery
- 5.4.1. Global Lymphedema Treatment Market, by Surgery, by Region, 2018 - 2030 (USD Million)
- 5.5. Drug Therapy
- 5.5.1. Global Lymphedema Treatment Market, by Drug Therapy, by Region, 2018 - 2030 (USD Million)
- 5.6. Laser Therapy
- 5.6.1. Global Lymphedema Treatment Market, by Laser Therapy, by Region, 2018 - 2030 (USD Million)
- 5.7. Others
- 5.7.1. Global Lymphedema Treatment Market, by Others, by Region, 2018 - 2030 (USD Million)
- 6. Global Lymphedema Treatment Market, by Affected Area
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 6.3. Lower extremity
- 6.3.1. Global Lymphedema Treatment Market, by Lower extremity, by Region, 2018 - 2030 (USD Million)
- 6.4. Upper extremity
- 6.4.1. Global Lymphedema Treatment Market, by Upper extremity, by Region, 2018 - 2030 (USD Million)
- 6.5. Genitalia
- 6.5.1. Global Lymphedema Treatment Market, by Genitalia, by Region, 2018 - 2030 (USD Million)
- 7. Global Lymphedema Treatment Market, by End-Use
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 7.3. Hospital
- 7.3.1. Global Lymphedema Treatment Market, by Hospital, by Region, 2018 - 2030 (USD Million)
- 7.4. Specialty Clinics
- 7.4.1. Global Lymphedema Treatment Market, by Specialty Clinics, by Region, 2018 - 2030 (USD Million)
- 7.5. Specialty Clinics
- 7.5.1. Global Lymphedema Treatment Market, by Specialty Clinics, by Region, 2018 - 2030 (USD Million)
- 7.6. Others
- 7.6.1. Global Lymphedema Treatment Market, by Others, by Region, 2018 - 2030 (USD Million)
- 8. Global Lymphedema Treatment Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Lymphedema Treatment Market Assessment, By Geography, 2018 - 2030 (USD Million)
- 8.3. Lymphedema Treatment Market – North America
- 8.3.1. North America: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.3.2. North America: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.3.3. North America: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.3.4. Lymphedema Treatment Market – U.S.
- 8.3.4.1. U.S.: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.3.4.2. U.S.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.3.4.3. U.S.: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.3.5. Lymphedema Treatment Market – Canada
- 8.3.5.1. Canada: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.3.5.2. Canada.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.3.5.3. Canada: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.4. Lymphedema Treatment Market – Europe
- 8.4.1. Europe: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.4.2. Europe.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.4.3. Europe: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.4.4. Lymphedema Treatment Market – UK
- 8.4.4.1. UK: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.4.4.2. UK.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.4.4.3. UK: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.4.5. Lymphedema Treatment Market – France
- 8.4.5.1. France: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.4.5.2. France.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.4.5.3. France: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.4.6. Lymphedema Treatment Market – Germany
- 8.4.6.1. Germany: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.4.6.2. Germany.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.4.6.3. Germany: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.4.7. Lymphedema Treatment Market – Italy
- 8.4.7.1. Italy: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.4.7.2. Italy.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.4.7.3. Italy: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.4.8. Lymphedema Treatment Market – Spain
- 8.4.8.1. Spain: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.4.8.2. Spain.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.4.8.3. Spain: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.4.9. Lymphedema Treatment Market – Netherlands
- 8.4.9.1. Netherlands: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.4.9.2. Netherlands.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.4.9.3. Netherlands: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.4.10. Lymphedema Treatment Market – Austria
- 8.4.10.1. Austria: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.4.10.2. Austria.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.4.10.3. Austria: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.5. Lymphedema Treatment Market – Asia Pacific
- 8.5.1. Asia Pacific: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.5.2. Asia Pacific.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.5.3. Asia Pacific: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.5.4. Lymphedema Treatment Market – China
- 8.5.4.1. China: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.5.4.2. China.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.5.4.3. China: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.5.5. Lymphedema Treatment Market – India
- 8.5.5.1. India: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.5.5.2. India.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.5.5.3. India: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.5.6. Lymphedema Treatment Market – Malaysia
- 8.5.6.1. Malaysia: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.5.6.2. Malaysia.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.5.6.3. Malaysia: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.5.7. Lymphedema Treatment Market – Japan
- 8.5.7.1. Japan: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.5.7.2. Japan.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.5.7.3. Japan: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.5.8. Lymphedema Treatment Market – Indonesia
- 8.5.8.1. Indonesia: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.5.8.2. Indonesia.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.5.8.3. Indonesia: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.5.9. Lymphedema Treatment Market – South Korea
- 8.5.9.1. South Korea: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.5.9.2. South Korea.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.5.9.3. South Korea: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.6. Lymphedema Treatment Market – Middle East & Africa
- 8.6.1. Middle East & Africa: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.6.2. Middle East & Africa.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.6.3. Middle East & Africa: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.6.4. Lymphedema Treatment Market – Saudi Arabia
- 8.6.4.1. Saudi Arabia: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.6.4.2. Saudi Arabia.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.6.4.3. Saudi Arabia: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.6.5. Lymphedema Treatment Market – UAE
- 8.6.5.1. UAE: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.6.5.2. UAE.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.6.5.3. UAE: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.6.6. Lymphedema Treatment Market – Israel
- 8.6.6.1. Israel: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.6.6.2. Israel.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.6.6.3. Israel: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.6.7. Lymphedema Treatment Market – South Africa
- 8.6.7.1. South Africa: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.6.7.2. South Africa.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.6.7.3. South Africa: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.7. Lymphedema Treatment Market – Latin America
- 8.7.1. Latin America: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.7.2. Latin America.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.7.3. Latin America: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.7.4. Lymphedema Treatment Market – Mexico
- 8.7.4.1. Mexico: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.7.4.2. Mexico.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.7.4.3. Mexico: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.7.5. Lymphedema Treatment Market – Brazil
- 8.7.5.1. Brazil: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.7.5.2. Brazil.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.7.5.3. Brazil: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 8.7.6. Lymphedema Treatment Market – Argentina
- 8.7.6.1. Argentina: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
- 8.7.6.2. Argentina.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
- 8.7.6.3. Argentina: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
- 9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
- 10. Company Profiles
- 10.1. AIROS Medical Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Avet Pharmaceuticals Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Bio-compression Systems
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Cardinal Health
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Convatec Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Essity (BSN medical GmbH)
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Huntleigh Healthcare Limited
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. JUZO
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Koya Medical
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Lohmann & Rauscher
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Medi GmbH
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Mego Afek ltd.
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. PAUL HARTMANN
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. SIGVARIS GROUP
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. Smith+Nephew HERANTIS PHARMA Plc
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development
- 10.16. Tactile medical
- 10.16.1. Company Overview
- 10.16.2. Financial Performance
- 10.16.3. Product Benchmarking
- 10.16.4. Recent Development
- 10.17. ThermoTek
- 10.17.1. Company Overview
- 10.17.2. Financial Performance
- 10.17.3. Product Benchmarking
- 10.17.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
